Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?

Oliver Pickles; Lennard Lee; Thomas Starkey; Luke Freeman-Mills; Anna Olsson-Brown; Vinton Cheng; Daniel Hughes; Alvin Lee; Karin Purshouse; Gary Middleton

doi:10.1038/s41416-020-0930-7

King's College London

King's main site

Research portal

Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?

Research output: Contribution to journal › Comment/debate › peer-review

Oliver Pickles, Lennard Lee, Thomas Starkey, Luke Freeman-Mills, Anna Olsson-Brown, Vinton Cheng, Daniel Hughes, Alvin Lee, Karin Purshouse, Gary Middleton

Original language	English
Pages (from-to)	691-693
Number of pages	3
Journal	BJC: British Journal of Cancer
Volume	123
Issue number	5
DOIs	https://doi.org/10.1038/s41416-020-0930-7
Published	1 Sep 2020
Additional links	Link to publication in Scopus

King's Authors

Daniel Hughes (Cancer Imaging)

Abstract

The rapid emergence of COVID-19 has sent shockwaves through healthcare systems globally, with cancer patients at increased risk. The interplay of the virus and host immune system has been implicated in the development of ARDS. Immunotherapy agents have the potential to adversely potentiate this phenomenon, requiring careful real-world observation.

View graph of relations

King's College London - Homepage

Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?

King's Authors

Abstract

By the same authors

With some of the same researchers

From the same journal